Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

Wednesday’s trading has closed, but MYL is being traded in the after-hours session. After-Hours quote »
48.62
Delayed Data
As of 3:59pm ET
 +0.33 / +0.68%
Today’s Change
44.80
Today|||52-Week Range
76.69
-13.75%
Year-to-Date

Today’s Trading

Previous close48.29
Today’s open49.00
Day’s range47.60 - 49.43
Volume6,139,650
Average volume (3 months)7,250,161
Market cap$23.7B
Dividend yield--
Data as of 3:59pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)+48.10%
Earnings growth (this year)+18.14%
Earnings growth (next 5 years)+10.65%
Revenue growth (last year)+12.42%
P/E ratio21.0
Price/Sales2.89
Price/Book5.57

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+1.14+2.59%
PRGOPerrigo Company PLC+2.13+1.19%
INCYIncyte Corp+8.16+7.09%
BMRNBiomarin Pharmaceuti...+4.63+3.71%
Data as of 4:02pm ET, 09/02/2015

Financials

Next reporting dateOctober 29, 2015
EPS forecast (this quarter)$1.37
Annual revenue (last year)$7.8B
Annual profit (last year)$929.4M
Net profit margin11.97%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Potters Bar, Hertfordshire

Forecasts

Partner Offers